Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ( Site 0354)

Meldola, Forli-Cesena 47014

0 studies enrolling now · 1 studies all time

What they study most

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin

Studies at this site

• Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) — Stopped early